Graybug Announces Name And Trading Symbol Change To CalciMedica, Inc. And Has Changed Its Trading Symbol To "CALC"

3/20/23 1:25:24 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $GRAY alert in real time by email

Graybug Vision, Inc. (NASDAQ:GRAY) (Graybug) today announced that it has changed its name to CalciMedica, Inc. (the Company), which will become effective at 4:02 pm ET. In connection with the name change, the Company has changed its trading symbol to "CALC." The Company's common stock will commence trading on March 21, 2023 on the Nasdaq Global Market under the trading symbol "CALC." The name and trading symbol change were undertaken in connection with the previously announced merger between Graybug and CalciMedica, Inc. (CalciMedica).

Get the next $GRAY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GRAY

Date	Price Target	Rating	Analyst

More analyst ratings

$GRAY
Financials

Live finance-specific insights

Graybug and CalciMedica Enter into Definitive Merger Agreement
– Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica's pipeline of first-in-class product candidates for life-threatening inflammatory diseases – Combined company is expected to be funded with cash and cash equivalents of approximately $35 million at closing, with an expected runway into the second half of 2024 – Phase 2b results in acute pancreatitis for lead product candidate Auxora expected in second half of 2023 – Companies will host joint webcast on November 22, 2022, at 8:00 a.m. Eastern Time REDWOOD CITY, Calif. and LA JOLLA, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (NASDAQ:GRAY) (Graybug) and CalciMedi
11/21/22 6:52:03 PM ET
$GRAY
Biotechnology: Pharmaceutical Preparations
Health Care
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
REDWOOD CITY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (NASDAQ:GRAY) ("Graybug" or the "Company"), a clinical-stage biopharmaceutical company focused historically on developing transformative medicines for ocular diseases, today reported financial results for the three and nine months ended September 30, 2022. Financial Results for the Three Months Ended September 30, 2022 Net loss for the quarter ended September 30, 2022 was $9.8 million compared to $8.0 million for the same period in 2021. Research and development expense for the quarter ended September 30, 2022 was $3.2 million compared to $4.0 million for the same period in 2021. The decrease was primarily due
11/10/22 4:58:58 PM ET
$GRAY
Biotechnology: Pharmaceutical Preparations
Health Care
Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments
BALTIMORE, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (NASDAQ:GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for ocular diseases, today provided an update on recent corporate developments and anticipated milestones, and reported financial results for the three and six months ended June 30, 2022. Recent Corporate Developments Announced review of strategic alternatives — On June 28, 2022, Graybug announced that its Board of Directors would conduct a comprehensive review of strategic alternatives focused on maximizing shareholder value. Alternatives being explored include the potential for an acquisition, company sale, merger, d
8/11/22 7:30:00 AM ET
$GRAY
Biotechnology: Pharmaceutical Preparations
Health Care

$GRAY
Press Releases

Fastest customizable press release news feed in the world

Graybug Announces Name and Trading Symbol Change
REDWOOD CITY, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (NASDAQ:GRAY) (Graybug) today announced that it has changed its name to CalciMedica, Inc. (the Company), which will become effective at 4:02 pm ET. In connection with the name change, the Company has changed its trading symbol to "CALC." The Company's common stock will commence trading on March 21, 2023 on the Nasdaq Global Market under the trading symbol "CALC." The name and trading symbol change were undertaken in connection with the previously announced merger between Graybug and CalciMedica, Inc. (CalciMedica). About GraybugGraybug is a clinical-stage biopharmaceutical company focused on developing transform
3/20/23 1:22:24 PM ET
$GRAY
Biotechnology: Pharmaceutical Preparations
Health Care
Graybug and CalciMedica Enter into Definitive Merger Agreement
– Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica's pipeline of first-in-class product candidates for life-threatening inflammatory diseases – Combined company is expected to be funded with cash and cash equivalents of approximately $35 million at closing, with an expected runway into the second half of 2024 – Phase 2b results in acute pancreatitis for lead product candidate Auxora expected in second half of 2023 – Companies will host joint webcast on November 22, 2022, at 8:00 a.m. Eastern Time REDWOOD CITY, Calif. and LA JOLLA, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (NASDAQ:GRAY) (Graybug) and CalciMedi
11/21/22 6:52:03 PM ET
$GRAY
Biotechnology: Pharmaceutical Preparations
Health Care
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
REDWOOD CITY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (NASDAQ:GRAY) ("Graybug" or the "Company"), a clinical-stage biopharmaceutical company focused historically on developing transformative medicines for ocular diseases, today reported financial results for the three and nine months ended September 30, 2022. Financial Results for the Three Months Ended September 30, 2022 Net loss for the quarter ended September 30, 2022 was $9.8 million compared to $8.0 million for the same period in 2021. Research and development expense for the quarter ended September 30, 2022 was $3.2 million compared to $4.0 million for the same period in 2021. The decrease was primarily due
11/10/22 4:58:58 PM ET
$GRAY
Biotechnology: Pharmaceutical Preparations
Health Care

$GRAY
Market Insights

Live Market Insights

Stocks That Hit 52-Week Lows On Monday
On Monday, 198 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Equity Residential (NYSE:EQR) was the biggest company by market cap to set a new 52-week low. The smallest company by market cap to hit a new 52-week low was CNS Pharmaceuticals (NASDAQ:CNSP). Graybug Vision (NASDAQ:GRAY) shares traded down 1205.63% to reach its 52-week low, making it the biggest loser. VBI Vaccines (NASDAQ:VBIV)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low. Stocks that set new 52-week lows on Monday are as follows: Equity Residential (NYSE:EQR) stock dropped to a yearly low on Monday of $57.10. Shares traded up 0.64%. CF Ind
3/20/23 1:29:01 PM ET
$VGAS
$VORB
$VTSI
$WISA
Major Chemicals
Industrials
Miscellaneous manufacturing industries
Consumer Discretionary
Graybug Announces Name And Trading Symbol Change To CalciMedica, Inc. And Has Changed Its Trading Symbol To "CALC"
Graybug Vision, Inc. (NASDAQ:GRAY) (Graybug) today announced that it has changed its name to CalciMedica, Inc. (the Company), which will become effective at 4:02 pm ET. In connection with the name change, the Company has changed its trading symbol to "CALC." The Company's common stock will commence trading on March 21, 2023 on the Nasdaq Global Market under the trading symbol "CALC." The name and trading symbol change were undertaken in connection with the previously announced merger between Graybug and CalciMedica, Inc. (CalciMedica).
3/20/23 1:25:24 PM ET
$GRAY
Biotechnology: Pharmaceutical Preparations
Health Care
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 152 stocks made new 52-week lows. Areas of Interest About Today's 52-Week Lows: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a new 52-week low. Pingtan Marine Enterprise (NASDAQ:PME) was the smallest company in terms of market cap to set a new 52-week low. Pingtan Marine Enterprise (NASDAQ:PME) shares traded down 99.97% to reach its 52-week low, making it the biggest loser. SmartRent (NYSE:SMRT) saw the sharpest rebound, as shares ascended 0.0%, reversing after hiting a new 52-week low. The following stocks created new 52-week lows on Wednesday: Tesla (NASDAQ:TSLA) shares moved up 1.51% on Wednesday to hit a new 52-week low of $135.89, dr
12/21/22 11:58:13 AM ET
$PME
$PRSO
$PSNL
$PTN
Semiconductors
Technology
Medical Specialities
Health Care

Graybug Announces Name And Trading Symbol Change To CalciMedica, Inc. And Has Changed Its Trading Symbol To "CALC"

Chat with this insight

Recent Analyst Ratings for $GRAY

$GRAY Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13D/A filed by Graybug Vision Inc. (Amendment)

SEC Form SC 13G/A filed by Graybug Vision Inc. (Amendment)

SEC Form SC 13G/A filed by Graybug Vision Inc. (Amendment)

$GRAY Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

$GRAY Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Sanderling Venture Partners Vi Lp bought $2,515,080 worth of shares (679,384 units at $3.70), increasing direct ownership by 35% to 946,744 units (SEC Form 4)

Middleton Fred A bought $2,515,080 worth of shares (679,384 units at $3.70) (SEC Form 4)

Wilson Robert N bought $1,670 worth of shares (506 units at $3.30), increasing direct ownership by 0.28% to 182,161 units (SEC Form 4)

Roberts Eric W was granted 91,086 shares, increasing direct ownership by 449% to 111,373 units (SEC Form 4)

Sanderling Venture Partners Vi Lp bought $2,515,080 worth of shares (679,384 units at $3.70), increasing direct ownership by 35% to 946,744 units (SEC Form 4)

Middleton Fred A bought $2,515,080 worth of shares (679,384 units at $3.70) (SEC Form 4)

$GRAY Leadership Updates

Live Leadership Updates

Graybug Vision Appoints Dirk Sauer to Board of Directors

Graybug Vision Appoints Bettina Maunz as Chief People Officer, Expanding the Company’s Executive Team

$GRAY Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$GRAY SEC Filings

Graybug Vision downgraded by SVB Leerink with a new price target

Graybug Vision downgraded by Needham

SVB Leerink reiterated coverage on Graybug Vision with a new price target

Graybug Vision Inc. filed SEC Form 8-K: Regulation FD Disclosure

SEC Form EFFECT filed by Graybug Vision Inc.

SEC Form S-3 filed by Graybug Vision Inc.

$GRAY Financials

Live finance-specific insights

Graybug and CalciMedica Enter into Definitive Merger Agreement

Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022

Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments

$GRAY Press Releases

Fastest customizable press release news feed in the world